Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time, and attempts to address it require a clear understanding of how ecological communities respond to environmental change across time and space. While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes, vast areas of the tropics remain understudied. In the American tropics, Amazonia stands out as the world's most diverse rainforest and the primary source of Neotropical biodiversity, but it remains among the least known forests in America and is often underrepresented in biodiversity databases. To worsen this situation, human-induced modifications may eliminate pieces of the Amazon's biodiversity puzzle before we can use them to understand how ecological communities are responding. To increase generalization and applicability of biodiversity knowledge, it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple organism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region's vulnerability to environmental change. 15%–18% of the most neglected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lost

Tratamento pelo fluconazol de pacientes imuno-comprometidos com graves infecções fúngicas Treatment by fluconazole of severe fungal infections in immunocompromised patients

Avaliou-se a eficácia do fluconazol no tratamento de infecções fúngicas em 108 pacientes imunocomprometidos. As doses iniciais variaram de 50 a mais de 400 mg/dia. Dos 108 pacientes, 57 (52,8%) tinham criptococose, 45 (41,7%) candidíase e 6 (5,5%) outras infecções fúngicas, sendo que 66,6% dos pacientes eram portadores de AIDS. Dos 57 pacientes com criptococose houve acometimento do SNC em 52 (91,2%); 39 de 43 pacientes com criptococose (90,7%) e 36 de 39 dos portadores de candidíase (92,3%) curaram ou tiveram boa evolução clínica. A erradicação do fungo ocorreu em 19 de 30 casos com criptococose (63,3%) e em 21 de 26 casos com candidíase (80,7%) que puderam ser avaliados. Onze dos 108 pacientes (10,2%) apresentaram reações adversas,principalmente gastrintestinais de pequena intensidade, porém um paciente apresentou envolvimento hepático na vigência de terapêutica com fluconazol. Conclui-se que o fluconazol é droga eficaz e de baixa toxicidade para tratar criptococose e candidíase, constituindo-se boa alternativa à terapêutica convencional com anfotericina B.<br>Fluconazole therapy was evaluated prospec-tively in 108 patients with immunossupression and serious fungal infections. Patients were enrolled if they had a life-threatening fungal infection and conventional therapy had failed to eradicate infection, had caused serious toxic reactions, or was contraindicated. Patients were treated with 50 to over 400 mg/day initially. AIDS was underlying risk factor in 66.6% of the patients evaluated in the study and in 92.9% of 57 patients with cryptococcal infection. Satisfactory clinical response was observed in 43 patients with active cryptococcal infection and in 39 patients with active candidiasis, 90.7% and 92.3% respectively. Concerning mycologic response, 63.3% and 80.7% of 30 patients with cryptococcal infection and 26 patients with candidiasis respectively had final negative cultures. Eleven patients (10.2%) had adverses effects possibly due to fluconazole therapy. Fluconazole may be effective in the treatment of cryptococcal infection and candidiasis and can be an alternative to conventional antifungal therapy

Associations between early-life growth pattern and body size and follicular lymphoma risk and survival : a family-based case-control study

Background: The influence of early-life growth pattern and body size on follicular lymphoma (FL) risk and survival is unclear. In this study, we aimed to investigate the association between gestational age, growth during childhood, body size, changes in body shape over time, and FL risk and survival. Methods: We conducted a population-based family case-control study and included 706 cases and 490 controls. We ascertained gestational age, growth during childhood, body size and body shape using questionnaires and followed-up cases (median=83 months) using record linkage with national death records. We used a group-based trajectory modeling approach to identify body shape trajectories from ages 5–70. We examined associations with FL risk using unconditional logistic regression and used Cox regression to assess the association between body mass index (BMI) and all-cause and FL-specific mortality among cases. Results: We found no association between gestational age, childhood height and FL risk. We observed a modest increase in FL risk with being obese 5 years prior to enrolment (OR=1.43, 95 %CI=0.99–2.06; BMI ≥30 kg/m2) and per 5-kg/m2 increase in BMI 5 years prior to enrolment (OR=1.14, 95 %CI=0.99–1.31). The excess risk for obesity 5 years prior to enrolment was higher for ever-smokers (OR=2.00, 95 %CI=1.08–3.69) than never-smokers (OR=1.14, 95 %CI=0.71–1.84). We found no association between FL risk and BMI at enrolment, BMI for heaviest lifetime weight, the highest categories of adult weight or height, trouser size, body shape at different ages or body shape trajectory. We also observed no association between all-cause or FL-specific mortality and excess adiposity at or prior to enrolment. Conclusion: We observed a weak association between elevated BMI and FL risk, and no association with all-cause or FL-specific mortality, consistent with previous studies. Future studies incorporating biomarkers are needed to elucidate possible mechanisms underlying the role of body composition in FL etiology

The use of medicinal plants by an indigenous Pataxó community in NE Brazil O uso de plantas medicinais por uma comunidade indígena Pataxó no NE do Brasil

We identified and classified 48 medicinal plants used by the Pataxó Indians in south Bahia, Brazil. The location is an ecologically threatened area designated by UNESCO as a World Heritage Site. The aim of this paper is to document phytotherapeutic practices in the indigenous community of Mata Medonha. We conducted interviews with the 25 families present at the area. Of the 48 medicinal species identified, only 14 (29%) had been examined for mechanism of action or isolation of biochemical compounds, according to bibliographic research. The plants were deposited at the Alexandre Leal Costa Herbarium of the Federal University of Bahia. We gathered information about the preparation and uses of the plants. The species are used for a variety of maladies, including flu, congestion, bronchitis and headaches, pain, snake bites, and some were only used for women's disorders. The Pataxó ethnopharmacological knowledge is under pressure from the economic outmigration of the community and threats to the biodiversity from logging, mining, and tourism. The plants studied here include important drug candidates. Additional research on the molecular aspects of the species cited should be performed.<br>Foram identificadas e classificadas 48 plantas medicinais usadas por Índios Pataxós no sul da Bahia. A região é área de risco ecológico designada pela UNESCO como Sítio do Patrimônio Mundial. O objetivo deste estudo foi de documentar as práticas fitoterápicas na comunidade indígena da Mata Medonha. Foram conduzidas entrevistas com as 25 famílias presentes no local. Dentre as 48 espécies identificadas, apenas 14 (29%) foram avaliadas quanto ao mecanismo de ação ou isolamento de compostos químicos, de acordo com levantamento bibliográfico. As plantas foram depositadas no Herbário Alexandre Leal Costa da Universidade Federal da Bahia. Foram registradas informações sobre o preparo e uso das plantas citadas. As espécies são usadas para uma variedade de doenças incluindo gripe, congestão, bronquite, dores em geral, picadas de cobra e algumas apenas para doenças femininas. O conhecimento etnofarmacológico Pataxó está sobre pressão pelas migrações para fora da comuindade e ameaças à biodiversidade por desmatamento, mineração e turismo. As plantas estudadas incluem importantes candidatos a fármacos. Pesquisas adicionais sobre os aspectos moleculares devem ser realizadas

Perceived Dissimilarity and Perspective Taking Within Work Teams

The authors investigate the relationship between employee perceptions of surface- and deep-level dissimilarity and within-team perspective taking. Results suggest that the more dissimilar employees perceive themselves to be from their fellow team members in terms of their work style, the less their perspective taking (i.e., lower positive attributions and empathy). In addition, the authors found that perceived work-style dissimilarity interacted with a contextually salient surface-level attribute (perceived age dissimilarity) such that when perceived work-style dissimilarity was low, perceived age dissim-ilarity had a stronger negative effect on within-team perspective taking. This study demonstrates the importance of considering perspective taking in their understanding of the effects of dissimilarity within teams and furthers theoretical understanding of the effects of relational demography by testing competing theories undergirding relational demography research

Effect of biomass on assemblages of large mammals in a seasonally dry forest in the Brazilian Amazonia

Aiming to understand the relationship between body mass and abundance, a community of middle-sized and larger mammals was studied in a seasonally dry forest in the far north of the Brazilian Amazonia. Diurnal and nocturnal surveys were carried out by the line-transect method along a 10-km transect. Data were collected on density, biomass, use of forest types, forest strata, diet and feeding strategies by the mammals. Biomass explained animal abundance better than did body mass across the two forest types: Terra Firme forest and mixed forest. There was a statistically significant positive relationship between the biomass of all the 33 mammals studied and group density, as well as between biomass and group size, in both forests. When terrestrial and arboreal mammals, and also different feeding guilds were considered separately, they exhibited very similar results, where biomass alone was positively associated with group density and group size. The slope of the relationships between body mass and group density, body mass and group size, biomass and group density, and biomass and group size varied considerably, with significant scatter around the regression line. Food and food competition shaped the relationship between animal mass and abundance, and this relationship can even vary widely between assemblages. As a result of competition for the available resources, group density increased with increasing biomass